Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod.
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.
Chemotactic Cytokines: Gordon Research Conference on Molecular and Cellular Mechanisms in Health and Disease
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab.
RTL therapy for multiple sclerosis: a Phase I clinical study.
Immune competence after alemtuzumab treatment of multiple sclerosis.
Breastfeeding and multiple sclerosis.
Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
Novantrone (mitoxantrone HCl) Injection February 2009
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
Adaptive myelination from fish to man.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
American Society for Cell Biology Annual Meeting
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Clinically feasible MTR is sensitive to cortical demyelination in MS.

Pages